ADVAN'CE'D

Clinical trials for ADVAN'CE'D explained in plain language.

Never miss a new study

Get alerted when new ADVAN'CE'D trials appear

Sign up with your email to follow new studies for ADVAN'CE'D, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New hope for advanced stomach cancer: immune-boosting combo enters trial

Disease control Not yet recruiting

This study tests a new drug, IBI363, combined with standard medicines for people with advanced stomach cancer that got worse after initial treatment. The goal is to see if the combination is safe and can shrink tumors or slow the disease. About 50 adults aged 18 to 75 will take p…

Matched conditions: ADVAN'CE'D

Phase: PHASE1, PHASE2 • Sponsor: The First Affiliated Hospital of Zhengzhou University • Aim: Disease control

Last updated May 26, 2026 12:01 UTC

ADVAN'CE'D

Get alerted when new ADVAN'CE'D trials appear

New hope for advanced stomach cancer: immune-boosting combo enters trial